Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Presta

Showing results (111-120 of 146) with videos related to

Pageof 15
Sort By:
The American Journal of Pathology|June 17, 1998
Impact of fibroblast growth factor-2 on tumor microvascular architecture. A tridimensional morphometric studyM A Konerding, E Fait, C Dimitropoulou, et al.
The Journal of Biological Chemistry|April 17, 2001
Pentosan polysulfate as an inhibitor of extracellular HIV-1 TatM Rusnati, C Urbinati, A Caputo, et al.
Biochemical and Biophysical Research Communications|June 30, 1992
Structure-function relationship of basic fibroblast growth factor: site-directed mutagenesis of a putative heparin-binding and receptor-binding regionM Presta, M Statuto, A Isacchi, et al.
The Journal of Biological Chemistry|July 27, 2001
Fibroblast growth factor-2 antagonist activity and angiostatic capacity of sulfated Escherichia coli K5 polysaccharide derivativesD Leali, M Belleri, C Urbinati, et al.
Journal of the American Academy of Dermatology|January 11, 2015
Impact of a Performance Improvement CME activity on the care and treatment of patients with psoriasisDebra L Gist, Reva Bhushan, Elaine Hamarstrom, et al.
Endothelium : Journal of Endothelial Cell Research|June 21, 2001
Activation of endothelial cell mitogen activated protein kinase ERK(1/2) by extracellular HIV-1 Tat proteinM Rusnati, C Urbinati, B Musulin, et al.
Blood|April 9, 1999
Human erythropoietin induces a pro-angiogenic phenotype in cultured endothelial cells and stimulates neovascularization in vivoD Ribatti, M Presta, A Vacca, et al.
Oncogene|January 18, 1996
HIV-tat protein is a heparin-binding angiogenic growth factorA Albini, R Benelli, M Presta, et al.
The Journal of Biological Chemistry|June 20, 1998
The basic domain in HIV-1 Tat protein as a target for polysulfonated heparin-mimicking extracellular Tat antagonistsM Rusnati, G Tulipano, C Urbinati, et al.
Blood|April 27, 1999
Bone marrow neovascularization, plasma cell angiogenic potential, and matrix metalloproteinase-2 secretion parallel progression of human multiple myelomaA Vacca, D Ribatti, M Presta, et al.
Pageof 15

Showing results (111-120 of 146) with videos related to

Sort By:
Pageof 15
The American Journal of Pathology|June 17, 1998
Impact of fibroblast growth factor-2 on tumor microvascular architecture. A tridimensional morphometric studyM A Konerding, E Fait, C Dimitropoulou, et al.
The Journal of Biological Chemistry|April 17, 2001
Pentosan polysulfate as an inhibitor of extracellular HIV-1 TatM Rusnati, C Urbinati, A Caputo, et al.
Biochemical and Biophysical Research Communications|June 30, 1992
Structure-function relationship of basic fibroblast growth factor: site-directed mutagenesis of a putative heparin-binding and receptor-binding regionM Presta, M Statuto, A Isacchi, et al.
The Journal of Biological Chemistry|July 27, 2001
Fibroblast growth factor-2 antagonist activity and angiostatic capacity of sulfated Escherichia coli K5 polysaccharide derivativesD Leali, M Belleri, C Urbinati, et al.
Journal of the American Academy of Dermatology|January 11, 2015
Impact of a Performance Improvement CME activity on the care and treatment of patients with psoriasisDebra L Gist, Reva Bhushan, Elaine Hamarstrom, et al.
Endothelium : Journal of Endothelial Cell Research|June 21, 2001
Activation of endothelial cell mitogen activated protein kinase ERK(1/2) by extracellular HIV-1 Tat proteinM Rusnati, C Urbinati, B Musulin, et al.
Blood|April 9, 1999
Human erythropoietin induces a pro-angiogenic phenotype in cultured endothelial cells and stimulates neovascularization in vivoD Ribatti, M Presta, A Vacca, et al.
Oncogene|January 18, 1996
HIV-tat protein is a heparin-binding angiogenic growth factorA Albini, R Benelli, M Presta, et al.
The Journal of Biological Chemistry|June 20, 1998
The basic domain in HIV-1 Tat protein as a target for polysulfonated heparin-mimicking extracellular Tat antagonistsM Rusnati, G Tulipano, C Urbinati, et al.
Blood|April 27, 1999
Bone marrow neovascularization, plasma cell angiogenic potential, and matrix metalloproteinase-2 secretion parallel progression of human multiple myelomaA Vacca, D Ribatti, M Presta, et al.
Pageof 15